Product NDC: | 52125-570 |
Proprietary Name: | Fexofenadine Hydrochloride |
Non Proprietary Name: | Fexofenadine HCl |
Active Ingredient(s): | 180 mg/1 & nbsp; Fexofenadine HCl |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-570 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079112 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130523 |
Package NDC: | 52125-570-21 |
Package Description: | 120 TABLET in 1 VIAL (52125-570-21) |
NDC Code | 52125-570-21 |
Proprietary Name | Fexofenadine Hydrochloride |
Package Description | 120 TABLET in 1 VIAL (52125-570-21) |
Product NDC | 52125-570 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fexofenadine HCl |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130523 |
Marketing Category Name | ANDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | FEXOFENADINE HYDROCHLORIDE |
Strength Number | 180 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |